Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

MEDIROM Healthcare Technologies (MRM) Stock Price & Analysis

131 Followers

MRM Stock Chart & Stats

$0.28-$0.01(-2.12%)
At close: 4:00 PM EST
$0.25$0.5$0.75$1Aug 17Aug 31Sep 14Sep 28Oct 12Oct 26Nov 9
Day’s Range
$0.28 - $0.32
52-Week Range
$0.25 - $2.33
Previous Close
$0.28
Volume
N/A
Average Volume (3M)
269.42K
Market Cap
$2.19M
Enterprise Value
$39.84M
Total Cash (Recent Filing)
$38.76M
Total Debt (Recent Filing)
$3.91B
Price to Earnings (P/E)
―
Beta
1.30
Next Earnings
May 17, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Recurring & Diversified Revenue Model

MEDIROM’s mix of tiered telemedicine subscriptions, product sales and service agreements builds recurring and diversified revenues. That business model provides predictable cash inflows, cross-sell opportunities and resilience versus single-product firms, supporting steadier medium-term growth.

Strategic World ID Infrastructure Win

The Master Service Agreement to roll out World ID Orbs at ~3,000 sites converts MEDIROM’s physical salon footprint into national authentication infrastructure. This creates a durable operational-fee revenue stream, strengthens network effects and positions the company as a strategic HealthTech/identity partner in Japan.

Expanded Distribution Via TD SYNNEX Partnership

Teaming with TD SYNNEX gives MEDIROM access to a large reseller network, accelerating device and system rollout nationwide. Improved distribution lowers go-to-market cost, speeds adoption of health-monitoring products and supports sustainable device and service revenue growth over the medium term.

Bears Say

High Leverage / Low Equity Ratio

A low equity ratio and material debt-to-equity indicate heavy reliance on debt financing. Elevated leverage raises interest expense and refinancing sensitivity, limiting strategic flexibility and increasing solvency risk if operational performance weakens over the next several quarters.

Deteriorating Free Cash Flow

A sharp drop in free cash flow and negative operating-cash-to-net-income metrics reflect liquidity stress. Persistent negative cash generation forces dependence on external financing, constraining the company’s ability to self-fund growth or absorb shocks in the medium term.

Profitability Shortfalls

Despite revenue gains and improving gross margins, MEDIROM reported negative EBIT and narrow profitability. Continued operating losses mean top-line growth is not yet translating into durable earnings or free cash flow, requiring further margin expansion or scale to reach self-sustaining profitability.

MEDIROM Healthcare Technologies News

MRM FAQ

What was MEDIROM Healthcare Technologies’s price range in the past 12 months?
MEDIROM Healthcare Technologies lowest stock price was $0.25 and its highest was $2.33 in the past 12 months.
What is MEDIROM Healthcare Technologies’s market cap?
MEDIROM Healthcare Technologies’s market cap is $2.19M.
When is MEDIROM Healthcare Technologies’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were MEDIROM Healthcare Technologies’s earnings last quarter?
MEDIROM Healthcare Technologies released its earnings results on Nov 10, 2025. The company reported -$0.589 earnings per share for the quarter.
Is MEDIROM Healthcare Technologies overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does MEDIROM Healthcare Technologies pay dividends?
MEDIROM Healthcare Technologies does not currently pay dividends.
What is MEDIROM Healthcare Technologies’s EPS estimate?
MEDIROM Healthcare Technologies’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does MEDIROM Healthcare Technologies have?
MEDIROM Healthcare Technologies has 7,901,950 shares outstanding.
What happened to MEDIROM Healthcare Technologies’s price movement after its last earnings report?
MEDIROM Healthcare Technologies reported an EPS of -$0.589 in its last earnings report. Following the earnings report the stock price went up 0.356%.
Which hedge fund is a major shareholder of MEDIROM Healthcare Technologies?
Currently, no hedge funds are holding shares in MRM
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology